← back to search

Yi Shi

Zhejiang International Studies University · CN
Area of research
Immunology · Physiology
Research interest
Research interests include Immune cells in cancer, Macrophage Migration Inhibitory Factor, Nitric Oxide and Endothelin Effects, and Phagocytosis and Immune Regulation.
h-index
54
citations
10,478
works
221
NIH funding
primary concept
email

Recent publications

Dimeric PKM2 in chondrocytes impairs mitochondrial homeostasis in osteoarthritis.
2026cited by 0position: contributordoi
NF Erythroid 2-Related Factor 2 Deficiency Enhances the Immunosuppressive Function of Monocytic Myeloid-Derived Suppressor Cells in a Peroxisome Proliferator-Activated Receptor- γ -Dependent Manner.
2025cited by 2position: contributordoi
The glycolytic enzyme PFKFB3 alleviates DNA damage and chondrocyte senescence in osteoarthritis.
2025cited by 0position: contributordoi
Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy
Cancer Research 2024cited by 29position: middledoi
Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy.
2024cited by 25position: contributordoi
Unilateral pulmonary edema after minimally-invasive bentall procedure - Case report.
2024cited by 1position: contributordoi
Data from Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy
2024cited by 1position: contributordoi
RIP1 inhibition reduces chondrocyte apoptosis through downregulating nuclear factor-kappa B signaling in a mouse osteoarthritis model.
2024cited by 0position: contributordoi
Supplementary materials and methods from Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy
2024cited by 0position: contributordoi
Supplementary Figure S4 from Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy
2024cited by 0position: contributordoi
Supplementary Figure S8 from Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy
2024cited by 0position: contributordoi
Data from Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy
2024cited by 0position: contributordoi
Supplementary Figure S1 from Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy
2024cited by 0position: contributordoi
Supplementary Figure S10 from Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy
2024cited by 0position: contributordoi
Supplementary tables from Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy
2024cited by 0position: contributordoi
Supplementary Figure S11 from Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy
2024cited by 0position: contributordoi
Supplementary Figure S6 from Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy
2024cited by 0position: contributordoi
Supplementary Figure S2 from Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy
2024cited by 0position: contributordoi
Supplementary Figure S3 from Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy
2024cited by 0position: contributordoi
Supplementary Figure S5 from Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy
2024cited by 0position: contributordoi
Supplementary Figure S8 from Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy
2024cited by 0position: contributordoi
Supplementary Figure S5 from Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy
2024cited by 0position: contributordoi
Supplementary Figure S3 from Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy
2024cited by 0position: contributordoi
Supplementary Figure S9 from Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy
2024cited by 0position: contributordoi
Supplementary Figure S7 from Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy
2024cited by 0position: contributordoi
Supplementary Figure S6 from Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy
2024cited by 0position: contributordoi
Supplementary tables from Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy
2024cited by 0position: contributordoi
Supplementary Figure S7 from Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy
2024cited by 0position: contributordoi
Supplementary Figure S11 from Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy
2024cited by 0position: contributordoi
Supplementary Figure S9 from Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy
2024cited by 0position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 38 papers (2020–2026)Qiongzhu Dong · Fudan University31 papers (2017–2024)Dongmei Gao · Qingdao University30 papers (2024–2024)Shaoqing Liu · First Affiliated Hospital of Zhengzhou University29 papers (2024–2024)Ming‐Hao Xu · Fudan University29 papers (2024–2024)Zheng Wang · Zhejiang Chinese Medical University29 papers (2024–2024)Min Xu · Shuguang Hospital29 papers (2024–2024)Ning Ren · Hangzhou First People's Hospital29 papers (2024–2024) · 29 papers (2024–2024) · 29 papers (2024–2024) · 29 papers (2024–2024) · 29 papers (2024–2024) · 29 papers (2024–2024) · 29 papers (2024–2024) · 29 papers (2024–2024) · 29 papers (2024–2024)Qiang Zhou · Anhui Medical University29 papers (2024–2024)Wenxin Xu · Shanghai Municipal Commission of Health and Family Planning29 papers (2024–2024)Fu Wang · Southwest Petroleum University29 papers (2024–2024)Hongli Gong · Fudan University3 papers (2013–2017)